Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome
– Study Did Not Achieve Statistical Significance in Primary or Key Secondary Endpoints in Full Analysis Set –– Achieved Statistical […]